Highlights from this issue
What you don't know can hurt you; early asymptomatic lung disease in cystic fibrosis
The new microbiology of cystic fibrosis
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis
Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis
Histamine-releasing factor
Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience
Tracheobronchial transplantation with a bioartifical nanocomposite
Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening
Restoration of function of the [INCREMENT]F508 mutation in cystic fibrosis
Progress in cystic fibrosis and the CF Therapeutics Development Network
Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin
Chronic obstructive pulmonary disease among residents of an historically industrialised area
Autoimmune disorders increase the risk of developing pulmonary embolism
Cigarette smoke and platelet-activating factor receptor dependent adhesion of Streptococcus pneumoniae to lower airway cells
Smoking, acute mountain sickness and altitude acclimatisation
The effect of continuous positive airway pressure usage on sleepiness in obstructive sleep apnoea
Salbutamol infusion worsens outcomes in ARDS
Necrotising pneumonia, pneumatoceles and the pneumococcus
Authors' response
Inequalities in outcomes for non-small cell lung cancer
Exposing children to secondhand smoke
Authors' response
Authors' response
British Thoracic Society national bronchiectasis audit 2010 and 2011
High doses of vitamin D may reduce exacerbations of chronic obstructive pulmonary disease
A therapeutic conundrum
Pulmonary complications of intravesicular BCG immunotherapy